Focus: Obesity Channel Featured Experts

Filters close
Newswise:Video Embedded a-powerhouse-of-obesity-research-then-and-now
VIDEO
Released: 13-Sep-2024 10:05 AM EDT
A Powerhouse of Obesity Research – Then and Now
UT Southwestern Medical Center

The “Ozempic Revolution” did not start with celebrities posting their weight-loss success stories on Instagram, or slick TV ads featuring the earworm jingle: “Oh, Oh, Oh, Ozempic!”

Newswise: Devise a dietary game plan for Super Bowl parties
Released: 2-Feb-2024 10:05 AM EST
Devise a dietary game plan for Super Bowl parties
UT Southwestern Medical Center

Football fans who plan to attend food-and-beverage-packed Super Bowl parties should have a dietary game plan to ensure that watching the big game is a healthy affair, according to a lifestyle medicine expert at UT Southwestern Medical Center.

Newswise: FDA approval for Zepbound: FSU researcher available for context on newly approved weight loss treatment
Released: 14-Nov-2023 3:05 PM EST
FDA approval for Zepbound: FSU researcher available for context on newly approved weight loss treatment
Florida State University

By: Bill Wellock | Published: November 14, 2023 | 2:43 pm | SHARE: The U.S. Food and Drug Administration recently approved the medication Zepbound for weight management treatment.Tirzepatide, the active ingredient in the Eli Lilly and Company’s trademarked Zepbound, was already approved to help improve blood sugar (glucose) in adults with type 2 diabetes mellitus.



close
2.42168